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Objectives: This study sought to determine the diagnostic utility of serum pre-albumin in predicting weight loss in hospitalised 
children.
Design: A hospital-based longitudinal survey was carried out between December 2013 and February 2014.
Setting: Aga Khan University Hospital, Nairobi, Kenya, a tertiary care hospital.
Subjects: A total of 170 children aged 29 days to 15 years who met the inclusion criteria were included in the study.
Outcome measures: Serum pre-albumin levels and weight were measured at admission and repeated after 48–96 h. Sensitivity, 
specificity, and positive and negative predictive values were calculated to determine the diagnostic utility of serum pre-albumin 
in predicting weight loss in hospitalised children.
Results: Of the 170 children studied, 57% and 60% had a drop in serum pre-albumin level and weight within the first four days 
of hospitalisation respectively. A drop in pre-albumin occurred in 68% of the 103 patients who had weight loss (p < 0.001). 
Using a serum pre-albumin cut off point of < 0.15 g/l at admission, sensitivity and specificity of serum pre-albumin in predicting 
weight loss were 76.7% and 29.0% (negative predictive value = 42.9%; positive predictive value = 64.2%). Positive and negative 
likelihood ratios were low at 1.08 and 0.8. The majority of the patients (72.3%) were already at risk of malnutrition as determined 
by the pre-albumin risk stratification on admission.
Conclusion: Serum pre-albumin is not an accurate surrogate for weight loss during hospitalisation. It is, however, useful in 
identifying patients at risk of malnutrition on admission and during hospitalisation.
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Introduction
Malnutrition among hospitalised children occurs as a result of 
reduction in food intake, increased dietary losses and increased 
calorie requirement as a result of disease-induced high catabolic 
state.1 A child’s nutritional status often deteriorates after 
admission to hospital;1–7 it occurs worldwide and affects patients 
of all ages.5 Researchers have reported a correlation between 
‘hospital-acquired’ malnutrition and the length of hospital stay, 
which in turn is associated with clinical deterioration and 
increased risk of complications, and increased use of hospital 
resources.3,4 There is, therefore, a need for health facilities to 
adopt a minimum set of tools for evaluating the nutritional 
status and to plan for its management in hospitalised children.
Although anthropometry is the most commonly used indicator 
for evaluating nutritional status and is generally considered to 
be a basic requirement of the admission process, it may be 
inappropriate for detecting acute nutritional changes over a 
short period;8 this could, for example, be the case in patients with 
dehydration or fluid accumulation. Moreover, many limitations 
exist within clinical practice including a lack of functioning and 
well-calibrated equipment and a lack of standardisation in 
recording of measurements.2 A biochemical nutritional marker 
with a short biological half-life, able to predict catabolic rate, that 
changes readily in response to protein intake and is uninfluenced 
by pathological processes would be a more sensitive surrogate 
predictor of acute weight loss.8,9 Biochemical markers that come 
close to meeting this requirement include serum albumin and 
pre-albumin.
Although serum albumin level has historically been used to 
determine nutritional status, it is relatively insensitive to acute 
changes in nutrition. This is because of its long half-life of 14–
20 days and its presence in a relatively large body pool besides 
being redistributed between the body’s vascular and interstitial 
spaces under various physiological conditions.10 Albumin levels 
typically take about 14 days to normalise after depletion of the 
entire body pool when appropriate nutrition is initiated.9,11 
Serum albumin is a relatively late marker thus rendering it 
inappropriate for assessment of changes in nutritional status 
during a brief hospitalisation.
Serum pre-albumin, a precursor of albumin, has been proposed 
as a more suitable marker for measuring rapid changes in 
nutritional status compared with albumin.9,11 It is easily 
measurable and, unlike other serum proteins, is less affected by 
liver disease.9,11 Although pre-albumin is produced primarily by 
the liver, its production is maintained until late in liver 
pathology.9,12 It is also produced by pancreatic islet cells within 
the embryonic yolk sac, choroid plexus, and by enterochromaffin 
cells in the gastrointestinal mucosa. Compared with other 
proteins in the body, pre-albumin is also considered a unique 
marker for protein synthesis due to its high essential to 
nonessential amino acid ratio.9,11 Unlike albumin, pre-albumin is 
unaffected by hydration9,13 and has a shorter half-life (2–4 days), 
therefore its level reflects recent dietary intake.14 Studies have 
shown that measurement of serum pre-albumin levels enables 
early recognition of acute malnutrition, before weight changes 
occur.9,13 Within four to eight days of starting nutritional 
supplementation pre-albumin levels are expected to rise, with a 
target increase of 2 mg/dl per day and a return to normal levels 
within eight days, which suggests adequate nutritional support. 
However, levels rising by less than 4 mg/dl in eight days indicate 
a poor prognosis and the need for intense enteral or parenteral 
nutritional support.9
Despite serum pre-albumin being considered a sensitive 
nutritional marker for some time, there are limited data on its 
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utility in children. This study investigated the diagnostic utility of 
serum pre-albumin in predicting weight loss among hospitalised 
children.
Methods
A longitudinal survey was carried out at the Aga Khan University 
Hospital, Nairobi (AKUH,N), a 254-bed private tertiary institution. 
The paediatric ward is a 30-bed-capacity unit, comprising a five-
bed paediatric high dependency unit and 25 general ward beds. 
The paediatric ward admits an average of 1 300 patients annually. 
The hospital largely serves Nairobi’s population but also receives 
referrals from other parts of the country and the wider Eastern 
African region.
Children aged between 29  days and 15  years and who were 
admitted for  ≥  48 h were eligible for inclusion. Those with 
oedematous malnutrition (presence of bilateral pitting oedema 
of nutritional origin) were, however, excluded. Informed written 
consent was obtained from parents or accompanying guardians 
before enlisting patients. Ethical approval for the study was 
obtained from the Aga Khan University Ethics Committee (Ref: 
2013/REC-39/v4, 09/12/2013).
The principal investigator or an assistant trained in taking 
anthropometric measurements took all the weights at admission 
and discharge using a Seca® (Birmingham, United Kingdom) 
digital baby-weighing scale for children less than 15 kg body 
weight, measured to the nearest 10 g. A Seca® (United Kingdom) 
standing weighing scale was used for children above 15 kg body 
weight and subjects were measured to the nearest 100  g. The 
two weighing scales were exclusively used to take weight for all 
the children. Participants were weighed undressed if  <  2  years 
and with minimal clothing (undergarment) for those above two 
years. In the case of dehydration, weight was repeated after 
adequate rehydration (defined using WHO criteria: child being 
alert, normal skin turgor, moist mucous membranes, flat anterior 
fontanel, eyes not sunken, warm extremities, capillary 
refill ≤ 2sec) and considered as the baseline. Assessment for re-
hydration was done by the attending clinician. Weight was taken 
daily under the same conditions (early in the morning, after 
voiding and before feeding).
Blood samples (2 ml each) for serum pre-albumin were taken at 
admission and between 48 and 96 h post-admission. These were 
done during routine sampling where applicable to minimise 
patient discomfort. Samples were labelled with the serial number 
of the patients and transported in a biohazard bag immediately 
after collection to the Aga Khan University Hospital, Nairobi 
laboratory where they were centrifuged, and the serum stored at 
–20  °C. The pre-albumin was measured using a commercially 
available, Cobas C Integra Pre-albumin Kit (Roche Diagnostics, 
Mannheim, Germany) with capacity to run 100 samples at a time. 
All the samples were analysed after completion of data collection 
to avoid wastage of pre-albumin kits. The assays were all 
performed by one technician who strictly followed the 
manufacturer’s protocol.
All children who were admitted to the hospital underwent 
routine nutritional assessment and received an appropriate diet 
plan recommended by the hospital’s nutritionist. The clinical 
team was informed of any children found to be malnourished 
based on anthropometry taken on admission. All patients were 
followed up till the point of discharge or death.
Demographic data and laboratory results of each patient were 
stored in a database using a Microsoft Excel® (Microsoft Corp, 
Redmond, WA, USA) database using a unique serial number as its 
identifier, so as to maintain patient anonymity. Data were 
regularly backed up both on- and off-site. Access to the results 
was restricted to the principal investigator and respective co-
investigators.
Data were collected from December 2013 to February 2014 and 
were analysed using Stata data and statistical software (Stata 
11.0®; StataCorp, College Station, TX, USA). Categorical data were 
analysed using proportions and continuous data were analysed 
using means, medians, standard deviation and interquartile 
range.
For the purpose of this study, weight loss was defined as ≥ 2% 
drop in weight from the time of admission to discharge. Patients 
were divided into two groups, those showing a  ≥  2% drop in 
weight from admission to discharge and those that showed 
either an increase in weight or < 2%/no change from admission 
to discharge.
Diagnostic utility of serum pre-albumin in predicting weight loss 
was calculated using a two-by-two contingency table with 
weight loss as gold standard. Sensitivity, specificity, positive and 
negative predictive values, and positive and negative likelihood 
ratios of serum pre-albumin against weight loss were also 
computed.
We used an ROC curve to determine the best serum pre-albumin 
cut-off point for predicting weight loss in hospitalised children. 
The area under the ROC curve (AUROC) was used to determine 
extent to which serum pre-albumin predicted weight loss. 
Discriminative power of the AUROC was categorised as: (i) not 
discriminative (< 0.5), (ii) poor–fair discrimination (0.5–0.7), (iii) 
acceptable discrimination (0.7–0.8), (iv) excellent discrimination 
(0.8–0.9) and (v) outstanding discrimination (≥ 0.9).
Risk of malnutrition on admission using levels of serum pre-
albumin was summarised using a pre-albumin risk stratification 
model by Bernstein et al.17 where normal  =  0.15–0.35  g/l, 
increased risk of malnutrition = 0.11–0.14 g/l, significant risk of 
malnutrition = 0.05–0.10 g/l and poor prognosis = < 0.05 g/l.
Results
A total of 210 patients were assessed for eligibility with 170 
participants fulfilling the inclusion criteria (Figure 1).
The median age of participants was 39.5  months (IQR 15–
89 months). The majority (62.4%) of the patients were below the 
age of 60 months. Ninety participants (52.9%) were boys and 80 
Figure 1: Flow chart of recruitment process.
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(47.1%) were girls, and the duration of hospital stay ranged from 
2 to 25  days (median three days; IQR 2–4). Gastrointestinal 
system conditions (mainly acute gastroenteritis and gastritis) 
were the most common on admission followed by respiratory 
system and central nervous system conditions (Table 1).
The median weight on admission was 14.8 kg (IQR 10.2–23.4). At 
discharge the median weight dropped to 14.15 kg (IQR 9.88–
23.3) and a mean drop of 0.5 kg (SD ± 3.37) was observed.
All age groups demonstrated a reduction in weight during 
hospitalisation; however, it was more common in children aged 
12–24  months (23/32, 71.9%), and lowest in those 
aged < 12 months (14/29, 48.3%). The greatest weight lost was 
observed among children diagnosed with gastroenteritis (26/32, 
81.3%), gastritis (9/14, 64.3%) and pneumonia (10/18, 55.6%).
Ninety-seven (57.1%) patients showed a decrease in their serum 
pre-albumin levels within 48–96 h post admission. Of the 103 
(60.6%) patients who lost weight from admission to discharge, 
70 (68%) demonstrated a decrease in serum pre-albumin 
(p < 0.001).
The sensitivity and specificity of serum pre-albumin using a cut 
off level of < 0.15 g/l on admission in predicting weight loss were 
76.7% (CI 67.3–84.5%) and 29.0% (CI 18.2–42.0%) respectively, 
with a negative predictive value (NPV) of 42.9% (CI 30.8–55.9%) 
and a positive predictive value (PPV) of 64.2% (CI 59.7–68.5%). 
Similarly, the positive likelihood ratio (LR+) and negative 
likelihood ratio (LR–) were 1.08 and 0.8 respectively (Table 2).
A graph of sensitivity versus specificity for serum pre-albumin in 
predicting children at risk of weight loss demonstrated a cross-
over point for sensitivity and specificity curves at 55%, which 
corresponded to serum pre-albumin level of 0.11 g/l (Figure 2). 
The best cut-off point for serum pre-albumin in predicting 
weight loss in hospitalised patients was thus identified to be 
0.11 g/l. Using this value, sensitivity dropped to 64.1% (95% CI 
56.9–71.3) with an increase in specificity to 49.3% (95% CI 41.7–
56.8).
The majority of the patients (72.3%) on admission were already 
at risk of malnutrition as determined by the pre-albumin risk 
stratification model of Bernstein et al.17 (Table 3). Nutritional 
status deteriorated in 19.4% (33/170) from admission to 
discharge based on this model (Fisher’s exact test < 0.001). Only 
1.8% (3/170) of patients had an increase of ≥ 2 mg/dl (0.02 g/l) 
per day, the cut-off point indicating adequate nutritional support 
in hospitalised patients.
Discussion
Currently, there is no consensus on the ideal method of assessing 
acute malnutrition occurring within the hospital setting. 
Although anthropometry is most commonly used as the 
reference, it is inappropriate for detecting acute nutritional 
changes over the period of a short hospital stay. Serum pre-
albumin has hence been proposed as a surrogate marker for 
detection of early protein malnutrition in situations of short 
hospital stay.9,11
As a measure of nutritional status, our study found 57.1% of 
patients had a drop in their serum pre-albumin levels within 
48–96 h post-admission. This incidence compared well with 
anthropometric assessment where we found 60.6% of children 
to have lost weight over the same period, a mean loss of 0.5 kg 
that corresponded to a 0.17% daily weight loss, which is the 
critical threshold for an adverse clinical outcome reported by 
Meritt and Blackburn.18
Of those 103 patients who demonstrated a drop in weight from 
admission to discharge, 70 (68%) had a drop in serum pre-
albumin (p < 0.001). To our knowledge, there is only one other 
study15 in children comparing serum pre-albumin and 
anthropometric measurements. However, unlike our study, that 
study was in an outpatient setting. The authors demonstrated 
that serum pre-albumin was not only able to distinguish between 
various grades of malnutrition, but was also the only parameter 
which could differentiate mild protein energy malnutrition (PEM) 
from normal when anthropometry, including weight, height and 
mid-arm circumference, was not sensitive to do so.
In our study, serum pre-albumin had a fairly good sensitivity 
(76.7%) but a poor specificity (29.0%) with low positive and 
negative predictive values. The ideal biochemical marker would 
be one that has a high sensitivity and specificity and also high 
positive and negative predictive values. These results are similar 
to those by Bulent et al.16 who demonstrated serum pre-albumin’s 
sensitivity, specificity, positive and negative predictive values in 
Table 1: General characteristics of patients admitted to the hospital 
children’s ward
Note: AKUH,N = Aga Khan University Hospital, Nairobi.





1 to ≤ 12 29 (17.1)
> 12 to ≤ 24 32 (18.8)
> 24 to ≤ 60 45 (26.5)
> 60 to ≤ 144 47 (27.6)
>144 17 (10.0)
Diagnosis on admission
Gastrointestinal conditions 65 (38.2)
Respiratory conditions 48 (28.2)
Neurological conditions 27 (15.9)
Others (haemato-oncological, endocrinological, cardiac, 
surgical, nephrological)
30(17.7)
Duration of hospital stay (days)
2 to ≤ 3 66 (38.8)
> 3 to ≤ 5 72 (42.4)
> 5 to ≤ 7 17 (10.0)
> 7 15 (8.8)
Table 2: Diagnostic utility of serum pre-albumin using anthropometry 
as gold standard




Positive 79 44 123
Negative 24 23 47
Total 103 67 170
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Conclusions
Malnutrition is an important problem among hospitalised 
patients affecting children of all age groups and is often 
overlooked during inpatient care. Currently there are limited 
data on the use of serum pre-albumin as a nutritional screening 
tool, but this study has highlighted the diagnostic utility of its 
use in predicting weight loss among hospitalised children. 
Although it may have some use in identifying and monitoring 
nutritional status, it is only moderately sensitive in predicting 
weight loss among hospitalised children.
Further studies on the utility of various screening tools for 
identifying and monitoring patients at risk of hospital 
malnutrition on admission and during hospitalisation are 
needed.
Study limitations
A precision error of 7.5% was used for estimation of sample size 
estimation, due to time restrictions. However, estimation of 95% 
CI provides the level of precision attained. A larger study would 
have provided more power to attain a closer interval.
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